Medra Corporation
MDRA · OTC
12/31/2001 | 12/31/2000 | 12/31/1999 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | 0.54 | -0.20 | 0.00 |
| FCF Yield | -35.26% | -18.35% | -4.71% |
| EV / EBITDA | -1.71 | -5.86 | -12.63 |
| Quality | |||
| ROIC | 0.00% | 0.00% | 0.00% |
| Gross Margin | 8.70% | 24.17% | 38.81% |
| Cash Conversion Ratio | 0.59 | 0.70 | 0.56 |
| Growth | |||
| Revenue 3-Year CAGR | 28.14% | 986,915.81% | 815,830.16% |
| Free Cash Flow Growth | 22.91% | -259.30% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | 0.04 | -0.10 | 0.33 |
| Interest Coverage | 0.00 | 0.00 | 0.00 |
| Efficiency | |||
| Inventory Turnover | 1.97 | 1.38 | 2.61 |
| Cash Conversion Cycle | 96.24 | 7.73 | 95.86 |